BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed JAZZ catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:cbc4858552fcf750f3be@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:JAZZ P2 readout (est.): A Phase 2 Study of Zanidatamab in Patients 
 With HER2-expressing Tumors
DESCRIPTION:A Phase 2 Study of Zanidatamab in Patients With HER2-expressing
  Tumors\nNCT06695845 | PHASE2 | RECRUITING | sponsor: Jazz Pharmaceuticals
 \nPrimary completion date (ESTIMATED)\; top-line results usually follow la
 ter.\nTicker JAZZ (confidence 0.9)\nSource: https://clinicaltrials.gov/stu
 dy/NCT06695845\nScheduling/reference data from public records\; dates can 
 move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06695845
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:169ce390474878581a9c@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260825
DTEND;VALUE=DATE:20260826
SUMMARY:JAZZ APPROVAL: ZIIHERA
DESCRIPTION:Approved 2026-08-25: ZIIHERA (BLA761416 SUPPL2)\nConfidence: co
 nfirmed\nTicker JAZZ (confidence 0.6)\nSource: https://www.accessdata.fda.
 gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761416\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=761416
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:91c24beb0ce9c64062b9@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260127
DTEND;VALUE=DATE:20260128
SUMMARY:JAZZ APPROVAL: VYXEOS
DESCRIPTION:Approved 2026-01-27: VYXEOS (NDA209401 SUPPL18)\nConfidence: co
 nfirmed\nTicker JAZZ (confidence 0.6)\nSource: https://www.accessdata.fda.
 gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209401\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=209401
CATEGORIES:approval,confirmed
END:VEVENT
END:VCALENDAR
